ESC 365 - Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease

ESC Premium Access

Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease

Session: PAD and cardiac disease - a permanent cross-talk

Topic: Pathophysiology, epidemiology

Speaker: Doctor J. Berger (New York, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Jeffrey Berger

New York University School of Medicine, New York (United States of America)

0 follower

4 more presentations in this session

State of the Art: PAD and atrial fibrillation - A dreadful combination

Speaker: Professor C. Espinola-Klein (Mainz, DE)

Peripheral arterial disease in a cohort of atrial fibrillation patients. The Atrial Fibrillation Follow Up Investigation Of Rhythm Management (AFFIRM) study.

Speaker: Mr A. Vitalis (Colchester, GB)

Different cardiovascular outcomes in patients with myocardial infarction and peripheral arterial disease - Swedish nationwide data

Speaker: Doctor B. Sigvant (Karlstad, SE)

PAD and heart failure: more than a random finding

Speaker: Doctor S. Kownator (Thionville, FR)

Access the full session

PAD and cardiac disease - a permanent cross-talk

Speakers: Doctor J. Berger, Professor C. Espinola-Klein, Mr A. Vitalis, Doctor B. Sigvant, Doctor S. Kownator

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources